We've found
184,457
clinical trials
Hypertension Clinical Trial
Pharmacodynamic Equivalence of Ramipril 10 mg and Atorvastatin 40 mg Administered as a Cardiovascular (CV) Polypill Acetylsalicylic Acid-Atorvastatin-Ramipril (AAR) as Compared to Monotherapy
Status: Enrolling,
Phase
II
Updated: 4/3/2017
Click here to add this to my saved trials
Hypertension Clinical Trial
Pharmacodynamic Equivalence of Ramipril 10 mg and Atorvastatin 40 mg Administered as a Cardiovascular (CV) Polypill Acetylsalicylic Acid-Atorvastatin-Ramipril (AAR) as Compared to Monotherapy
Status: Enrolling,
Phase
II
Updated: 4/3/2017
Click here to add this to my saved trials
Hypertension Clinical Trial
Pharmacodynamic Equivalence of Ramipril 10 mg and Atorvastatin 40 mg Administered as a Cardiovascular (CV) Polypill Acetylsalicylic Acid-Atorvastatin-Ramipril (AAR) as Compared to Monotherapy
Status: Enrolling,
Phase
II
Updated: 4/3/2017
Click here to add this to my saved trials
Hypertension Clinical Trial
Pharmacodynamic Equivalence of Ramipril 10 mg and Atorvastatin 40 mg Administered as a Cardiovascular (CV) Polypill Acetylsalicylic Acid-Atorvastatin-Ramipril (AAR) as Compared to Monotherapy
Status: Enrolling,
Phase
II
Updated: 4/3/2017
Click here to add this to my saved trials
Colitis, Ulcerative Clinical Trial
Phase 4 Study to Evaluate the Efficacy and Safety of Vedolizumab in the Treatment of Chronic Pouchitis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Exercise Program in Cancer and Cognition
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Study to Assess the Efficacy and Safety of Ublituximab + TGR-1202 With or Without Bendamustine and TGR-1202 Alone in Patients With Previously Treated Non-Hodgkins Lymphoma
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Study to Assess the Efficacy and Safety of Ublituximab + TGR-1202 With or Without Bendamustine and TGR-1202 Alone in Patients With Previously Treated Non-Hodgkins Lymphoma
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Study to Assess the Efficacy and Safety of Ublituximab + TGR-1202 With or Without Bendamustine and TGR-1202 Alone in Patients With Previously Treated Non-Hodgkins Lymphoma
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Study to Assess the Efficacy and Safety of Ublituximab + TGR-1202 With or Without Bendamustine and TGR-1202 Alone in Patients With Previously Treated Non-Hodgkins Lymphoma
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Study to Assess the Efficacy and Safety of Ublituximab + TGR-1202 With or Without Bendamustine and TGR-1202 Alone in Patients With Previously Treated Non-Hodgkins Lymphoma
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Study to Assess the Efficacy and Safety of Ublituximab + TGR-1202 With or Without Bendamustine and TGR-1202 Alone in Patients With Previously Treated Non-Hodgkins Lymphoma
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Study to Assess the Efficacy and Safety of Ublituximab + TGR-1202 With or Without Bendamustine and TGR-1202 Alone in Patients With Previously Treated Non-Hodgkins Lymphoma
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Study to Assess the Efficacy and Safety of Ublituximab + TGR-1202 With or Without Bendamustine and TGR-1202 Alone in Patients With Previously Treated Non-Hodgkins Lymphoma
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Study to Assess the Efficacy and Safety of Ublituximab + TGR-1202 With or Without Bendamustine and TGR-1202 Alone in Patients With Previously Treated Non-Hodgkins Lymphoma
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Study to Assess the Efficacy and Safety of Ublituximab + TGR-1202 With or Without Bendamustine and TGR-1202 Alone in Patients With Previously Treated Non-Hodgkins Lymphoma
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Study to Assess the Efficacy and Safety of Ublituximab + TGR-1202 With or Without Bendamustine and TGR-1202 Alone in Patients With Previously Treated Non-Hodgkins Lymphoma
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Study to Assess the Efficacy and Safety of Ublituximab + TGR-1202 With or Without Bendamustine and TGR-1202 Alone in Patients With Previously Treated Non-Hodgkins Lymphoma
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Study to Assess the Efficacy and Safety of Ublituximab + TGR-1202 With or Without Bendamustine and TGR-1202 Alone in Patients With Previously Treated Non-Hodgkins Lymphoma
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Study to Assess the Activity of Molecularly Matched Targeted Therapies in Select Tumor Types Based on Genomic Alterations
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Study to Assess the Activity of Molecularly Matched Targeted Therapies in Select Tumor Types Based on Genomic Alterations
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Study to Assess the Activity of Molecularly Matched Targeted Therapies in Select Tumor Types Based on Genomic Alterations
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Breast, Cervical or Colorectal Cancer Screening Needed Clinical Trial
Rural Interventions for Screening Effectiveness
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
HIV INfections Clinical Trial
Safety and Efficacy Study of Injectable Cabotegravir Compared to Daily Oral Tenofovir Disoproxil Fumarate/Emtricitabine (TDF/FTC), For Pre-Exposure Prophylaxis in HIV-Uninfected Cisgender Men and Transgender Women Who Have Sex With Men
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
HIV INfections Clinical Trial
Safety and Efficacy Study of Injectable Cabotegravir Compared to Daily Oral Tenofovir Disoproxil Fumarate/Emtricitabine (TDF/FTC), For Pre-Exposure Prophylaxis in HIV-Uninfected Cisgender Men and Transgender Women Who Have Sex With Men
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Patent Ductus Arteriosus Clinical Trial
PDA Post NICU Discharge
Status: Enrolling,
Phase
Updated: 4/27/2018
Click here to add this to my saved trials
Oncology Clinical Trial
Frameless Fractionated Stereotactic Radiation in Treating Patients With Brain Metastases
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Blunt Injury Clinical Trial
Thoracic Endovascular Repair Versus Open Surgery for Blunt Injury
Status: Enrolling
Updated: 6/14/2016
Click here to add this to my saved trials
Oncology Clinical Trial
Phase 1/2 Study of USL311 Alone and in Combination With Lomustine in Subjects With Advanced Solid Tumors and Relapsed/Recurrent Glioblastoma Multiforme (GBM)
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA
Status: Enrolling,
Phase
II
Updated: 2/28/2018
Click here to add this to my saved trials
Pain Clinical Trial
Local Infiltration Analgesia With and Without EXPAREL Following Total Knee Arthroplasty
Status: Enrolling,
Phase
IV
Updated: 6/15/2016
Click here to add this to my saved trials
Parkinson's Disease Clinical Trial
Pharmacokinetic Profile of Neupro Patch Administrated at 2 mg, 4 mg, 6 mg and 8 mg/Day Weekly in Patients With Early-stage Parkinson's Disease
Status: Enrolling,
Phase
I
Updated: 6/15/2016
Click here to add this to my saved trials
Acute Liver Failure Clinical Trial
13C-Methacetin Breath Test for the Prediction of Outcome in in ALI or ALF
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Acute Liver Failure Clinical Trial
13C-Methacetin Breath Test for the Prediction of Outcome in in ALI or ALF
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Acute Liver Failure Clinical Trial
13C-Methacetin Breath Test for the Prediction of Outcome in in ALI or ALF
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Acute Liver Failure Clinical Trial
13C-Methacetin Breath Test for the Prediction of Outcome in in ALI or ALF
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Treatment of Partial Thickness Burns Clinical Trial
Dehydrated Human Amnion Chorion Membrane (dHACM) vs. Control in the Treatment of Partial Thickness Burns.
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Retinoblastoma Clinical Trial
Intravitreal Carboplatin for the Treatment of Participants With Recurrent or Refractory Intraocular Retinoblastoma
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Labor and Delivery Clinical Trial
Epidural Loading: High Volume, Low Concentration
Status: Enrolling
Updated: 6/16/2016
Click here to add this to my saved trials
Atherosclerotic Cardiovascular Disease Clinical Trial
Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-term
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Atherosclerotic Cardiovascular Disease Clinical Trial
Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-term
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Atherosclerotic Cardiovascular Disease Clinical Trial
Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-term
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Provision of TCRγδ T Cells and Memory T Cells Plus Selected Use of Blinatumomab in Naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies Relapsed or Refractory Despite Prior Transplantation
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology Clinical Trial
The Hemophilia Ultrasound Project
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Ovarian Neoplasms Clinical Trial
Phase Ib Study of Anetumab Ravtansine in Combination With Pegylated Liposomal Doxorubicin in Patients With Recurrent Mesothelin-expressing Platinum-resistant Cancer
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Epilepsy, Unspecified, Refractory (Medically) Clinical Trial
MR-Guided Focused Ultrasound in the Treatment of Subcortical Lesional Epilepsy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Menorrhagia Clinical Trial
Ultrasound Appearance of the Endometrium Post Radio-Frequency Ablation
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Glaucoma Clinical Trial
The AGS Second Aqueous Shunt Implant vs. Transscleral Cyclophotocoagulation Treatment Study (ASSISTS)
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Glaucoma Clinical Trial
The AGS Second Aqueous Shunt Implant vs. Transscleral Cyclophotocoagulation Treatment Study (ASSISTS)
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Glaucoma Clinical Trial
The AGS Second Aqueous Shunt Implant vs. Transscleral Cyclophotocoagulation Treatment Study (ASSISTS)
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
A Study of ASP2215 (Gilteritinib) by Itself, ASP2215 Combined With Azacitidine or Azacitidine by Itself to Treat Adult Patients Who Have Recently Been Diagnosed With Acute Myeloid Leukemia With a FLT3 Gene Mutation and Who Cannot Receive Standard Chemotherapy
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
A Study of ASP2215 (Gilteritinib) by Itself, ASP2215 Combined With Azacitidine or Azacitidine by Itself to Treat Adult Patients Who Have Recently Been Diagnosed With Acute Myeloid Leukemia With a FLT3 Gene Mutation and Who Cannot Receive Standard Chemotherapy
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
A Study of ASP2215 (Gilteritinib) by Itself, ASP2215 Combined With Azacitidine or Azacitidine by Itself to Treat Adult Patients Who Have Recently Been Diagnosed With Acute Myeloid Leukemia With a FLT3 Gene Mutation and Who Cannot Receive Standard Chemotherapy
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
A Study of ASP2215 (Gilteritinib) by Itself, ASP2215 Combined With Azacitidine or Azacitidine by Itself to Treat Adult Patients Who Have Recently Been Diagnosed With Acute Myeloid Leukemia With a FLT3 Gene Mutation and Who Cannot Receive Standard Chemotherapy
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
A Study of ASP2215 (Gilteritinib) by Itself, ASP2215 Combined With Azacitidine or Azacitidine by Itself to Treat Adult Patients Who Have Recently Been Diagnosed With Acute Myeloid Leukemia With a FLT3 Gene Mutation and Who Cannot Receive Standard Chemotherapy
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Glaucoma Clinical Trial
Optical Coherence Tomography (OCT) Reference Data Collection Study (S-2015-1)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Expanded Access Program for Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
Status: Enrolling,
Phase
III
Updated: 5/8/2017
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Expanded Access Program for Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
Status: Enrolling,
Phase
III
Updated: 5/8/2017
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Expanded Access Program for Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
Status: Enrolling,
Phase
III
Updated: 5/8/2017
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Expanded Access Program for Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
Status: Enrolling,
Phase
III
Updated: 5/8/2017
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Expanded Access Program for Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
Status: Enrolling,
Phase
III
Updated: 5/8/2017
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Expanded Access Program for Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
Status: Enrolling,
Phase
III
Updated: 5/8/2017
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Expanded Access Program for Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
Status: Enrolling,
Phase
III
Updated: 5/8/2017
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Expanded Access Program for Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
Status: Enrolling,
Phase
III
Updated: 5/8/2017
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Expanded Access Program for Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
Status: Enrolling,
Phase
III
Updated: 5/8/2017
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Expanded Access Program for Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
Status: Enrolling,
Phase
III
Updated: 5/8/2017
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Expanded Access Program for Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
Status: Enrolling,
Phase
III
Updated: 5/8/2017
Click here to add this to my saved trials
Duchenne Muscular Dystrophy (DMD) Clinical Trial
A Phase III Double-blind Study With Idebenone in Patients With Duchenne Muscular Dystrophy (DMD) Taking Glucocorticoid Steroids
Status: Enrolling,
Phase
III
Updated: 4/25/2018
Click here to add this to my saved trials
Fabry Disease Clinical Trial
Study of the Safety and Efficacy of PRX-102 Compared to Agalsidase Beta on Renal Function
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Fabry Disease Clinical Trial
Study of the Safety and Efficacy of PRX-102 Compared to Agalsidase Beta on Renal Function
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Fracture Clinical Trial
Optimal Vitamin D3 Supplementation Strategies for Acute Fracture Healing
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Dravet Syndrome Clinical Trial
An Open-Label Extension Trial to Assess the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride HCl) Oral Solution in Children and Young Adults With Dravet Syndrome
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Dravet Syndrome Clinical Trial
An Open-Label Extension Trial to Assess the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride HCl) Oral Solution in Children and Young Adults With Dravet Syndrome
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Dravet Syndrome Clinical Trial
An Open-Label Extension Trial to Assess the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride HCl) Oral Solution in Children and Young Adults With Dravet Syndrome
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Normal Physiology Clinical Trial
Genomic Responses of Human Immune and Non-Immune Cells to Glucocorticoids
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Leukemia, Myeloid, Acute Clinical Trial
A Trial to Find and Investigate a Safe Dose of BI 836858 in Combination With Decitabine for Patients With Acute Myeloid Leukemia (AML)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology Clinical Trial
A Study of LY2951742 (Galcanezumab) in Participants With Cluster Headache
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology Clinical Trial
A Study of LY2951742 (Galcanezumab) in Participants With Cluster Headache
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology Clinical Trial
A Study of LY2951742 (Galcanezumab) in Participants With Cluster Headache
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology Clinical Trial
A Study of LY2951742 (Galcanezumab) in Participants With Cluster Headache
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrine Diseases Clinical Trial
Evaluation of Adults With Endocrine and Metabolic-Related Conditions
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Early Breast Cancer Clinical Trial
Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Early Breast Cancer Clinical Trial
Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Early Breast Cancer Clinical Trial
Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Early Breast Cancer Clinical Trial
Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Early Breast Cancer Clinical Trial
Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Early Breast Cancer Clinical Trial
Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Early Breast Cancer Clinical Trial
Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Early Breast Cancer Clinical Trial
Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Early Breast Cancer Clinical Trial
Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Early Breast Cancer Clinical Trial
Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Neuroblastoma Clinical Trial
Post-Marketing Assessment of Immunogenicity and Safety of Unituxin™ in High-Risk Neuroblastoma Patients
Status: Enrolling,
Phase
IV
Updated: 7/12/2016
Click here to add this to my saved trials
Neuroblastoma Clinical Trial
Post-Marketing Assessment of Immunogenicity and Safety of Unituxin™ in High-Risk Neuroblastoma Patients
Status: Enrolling,
Phase
IV
Updated: 7/12/2016
Click here to add this to my saved trials
Neuroblastoma Clinical Trial
Post-Marketing Assessment of Immunogenicity and Safety of Unituxin™ in High-Risk Neuroblastoma Patients
Status: Enrolling,
Phase
IV
Updated: 7/12/2016
Click here to add this to my saved trials
Neuroblastoma Clinical Trial
Post-Marketing Assessment of Immunogenicity and Safety of Unituxin™ in High-Risk Neuroblastoma Patients
Status: Enrolling,
Phase
IV
Updated: 7/12/2016
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
An Observational Study of Presentation, Treatment Patterns, and Outcomes in Multiple Myeloma Participants
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
An Observational Study of Presentation, Treatment Patterns, and Outcomes in Multiple Myeloma Participants
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
An Observational Study of Presentation, Treatment Patterns, and Outcomes in Multiple Myeloma Participants
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
An Observational Study of Presentation, Treatment Patterns, and Outcomes in Multiple Myeloma Participants
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Psychiatry / Psychology Clinical Trial
Exercise in Adults With Mild Memory Problems
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
We've found
184,457
clinical trials
Hypertension Clinical Trial
Updated: 4/3/2017
Pharmacodynamic Equivalence of Ramipril 10 mg and Atorvastatin 40 mg Administered as a Cardiovascular (CV) Polypill Acetylsalicylic Acid-Atorvastatin-Ramipril (AAR) as Compared to Monotherapy
Status: Enrolling,
Phase
II
Updated: 4/3/2017
Click here to add this to my saved trials
Hypertension Clinical Trial
Updated: 4/3/2017
Pharmacodynamic Equivalence of Ramipril 10 mg and Atorvastatin 40 mg Administered as a Cardiovascular (CV) Polypill Acetylsalicylic Acid-Atorvastatin-Ramipril (AAR) as Compared to Monotherapy
Status: Enrolling,
Phase
II
Updated: 4/3/2017
Click here to add this to my saved trials
Hypertension Clinical Trial
Updated: 4/3/2017
Pharmacodynamic Equivalence of Ramipril 10 mg and Atorvastatin 40 mg Administered as a Cardiovascular (CV) Polypill Acetylsalicylic Acid-Atorvastatin-Ramipril (AAR) as Compared to Monotherapy
Status: Enrolling,
Phase
II
Updated: 4/3/2017
Click here to add this to my saved trials
Hypertension Clinical Trial
Updated: 4/3/2017
Pharmacodynamic Equivalence of Ramipril 10 mg and Atorvastatin 40 mg Administered as a Cardiovascular (CV) Polypill Acetylsalicylic Acid-Atorvastatin-Ramipril (AAR) as Compared to Monotherapy
Status: Enrolling,
Phase
II
Updated: 4/3/2017
Click here to add this to my saved trials
Colitis, Ulcerative Clinical Trial
Updated: 12/31/1969
Phase 4 Study to Evaluate the Efficacy and Safety of Vedolizumab in the Treatment of Chronic Pouchitis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/31/1969
Exercise Program in Cancer and Cognition
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Study to Assess the Efficacy and Safety of Ublituximab + TGR-1202 With or Without Bendamustine and TGR-1202 Alone in Patients With Previously Treated Non-Hodgkins Lymphoma
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Study to Assess the Efficacy and Safety of Ublituximab + TGR-1202 With or Without Bendamustine and TGR-1202 Alone in Patients With Previously Treated Non-Hodgkins Lymphoma
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Study to Assess the Efficacy and Safety of Ublituximab + TGR-1202 With or Without Bendamustine and TGR-1202 Alone in Patients With Previously Treated Non-Hodgkins Lymphoma
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Study to Assess the Efficacy and Safety of Ublituximab + TGR-1202 With or Without Bendamustine and TGR-1202 Alone in Patients With Previously Treated Non-Hodgkins Lymphoma
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Study to Assess the Efficacy and Safety of Ublituximab + TGR-1202 With or Without Bendamustine and TGR-1202 Alone in Patients With Previously Treated Non-Hodgkins Lymphoma
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Study to Assess the Efficacy and Safety of Ublituximab + TGR-1202 With or Without Bendamustine and TGR-1202 Alone in Patients With Previously Treated Non-Hodgkins Lymphoma
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Study to Assess the Efficacy and Safety of Ublituximab + TGR-1202 With or Without Bendamustine and TGR-1202 Alone in Patients With Previously Treated Non-Hodgkins Lymphoma
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Study to Assess the Efficacy and Safety of Ublituximab + TGR-1202 With or Without Bendamustine and TGR-1202 Alone in Patients With Previously Treated Non-Hodgkins Lymphoma
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Study to Assess the Efficacy and Safety of Ublituximab + TGR-1202 With or Without Bendamustine and TGR-1202 Alone in Patients With Previously Treated Non-Hodgkins Lymphoma
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Study to Assess the Efficacy and Safety of Ublituximab + TGR-1202 With or Without Bendamustine and TGR-1202 Alone in Patients With Previously Treated Non-Hodgkins Lymphoma
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Study to Assess the Efficacy and Safety of Ublituximab + TGR-1202 With or Without Bendamustine and TGR-1202 Alone in Patients With Previously Treated Non-Hodgkins Lymphoma
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Study to Assess the Efficacy and Safety of Ublituximab + TGR-1202 With or Without Bendamustine and TGR-1202 Alone in Patients With Previously Treated Non-Hodgkins Lymphoma
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Study to Assess the Efficacy and Safety of Ublituximab + TGR-1202 With or Without Bendamustine and TGR-1202 Alone in Patients With Previously Treated Non-Hodgkins Lymphoma
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Study to Assess the Activity of Molecularly Matched Targeted Therapies in Select Tumor Types Based on Genomic Alterations
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Study to Assess the Activity of Molecularly Matched Targeted Therapies in Select Tumor Types Based on Genomic Alterations
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Study to Assess the Activity of Molecularly Matched Targeted Therapies in Select Tumor Types Based on Genomic Alterations
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Breast, Cervical or Colorectal Cancer Screening Needed Clinical Trial
Updated: 12/31/1969
Rural Interventions for Screening Effectiveness
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
HIV INfections Clinical Trial
Updated: 12/31/1969
Safety and Efficacy Study of Injectable Cabotegravir Compared to Daily Oral Tenofovir Disoproxil Fumarate/Emtricitabine (TDF/FTC), For Pre-Exposure Prophylaxis in HIV-Uninfected Cisgender Men and Transgender Women Who Have Sex With Men
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
HIV INfections Clinical Trial
Updated: 12/31/1969
Safety and Efficacy Study of Injectable Cabotegravir Compared to Daily Oral Tenofovir Disoproxil Fumarate/Emtricitabine (TDF/FTC), For Pre-Exposure Prophylaxis in HIV-Uninfected Cisgender Men and Transgender Women Who Have Sex With Men
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Patent Ductus Arteriosus Clinical Trial
Updated: 4/27/2018
PDA Post NICU Discharge
Status: Enrolling,
Phase
Updated: 4/27/2018
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Frameless Fractionated Stereotactic Radiation in Treating Patients With Brain Metastases
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Blunt Injury Clinical Trial
Updated: 6/14/2016
Thoracic Endovascular Repair Versus Open Surgery for Blunt Injury
Status: Enrolling
Updated: 6/14/2016
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Phase 1/2 Study of USL311 Alone and in Combination With Lomustine in Subjects With Advanced Solid Tumors and Relapsed/Recurrent Glioblastoma Multiforme (GBM)
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 2/28/2018
Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA
Status: Enrolling,
Phase
II
Updated: 2/28/2018
Click here to add this to my saved trials
Pain Clinical Trial
Updated: 6/15/2016
Local Infiltration Analgesia With and Without EXPAREL Following Total Knee Arthroplasty
Status: Enrolling,
Phase
IV
Updated: 6/15/2016
Click here to add this to my saved trials
Parkinson's Disease Clinical Trial
Updated: 6/15/2016
Pharmacokinetic Profile of Neupro Patch Administrated at 2 mg, 4 mg, 6 mg and 8 mg/Day Weekly in Patients With Early-stage Parkinson's Disease
Status: Enrolling,
Phase
I
Updated: 6/15/2016
Click here to add this to my saved trials
Acute Liver Failure Clinical Trial
Updated: 12/31/1969
13C-Methacetin Breath Test for the Prediction of Outcome in in ALI or ALF
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Acute Liver Failure Clinical Trial
Updated: 12/31/1969
13C-Methacetin Breath Test for the Prediction of Outcome in in ALI or ALF
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Acute Liver Failure Clinical Trial
Updated: 12/31/1969
13C-Methacetin Breath Test for the Prediction of Outcome in in ALI or ALF
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Acute Liver Failure Clinical Trial
Updated: 12/31/1969
13C-Methacetin Breath Test for the Prediction of Outcome in in ALI or ALF
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Treatment of Partial Thickness Burns Clinical Trial
Updated: 12/31/1969
Dehydrated Human Amnion Chorion Membrane (dHACM) vs. Control in the Treatment of Partial Thickness Burns.
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Retinoblastoma Clinical Trial
Updated: 12/31/1969
Intravitreal Carboplatin for the Treatment of Participants With Recurrent or Refractory Intraocular Retinoblastoma
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Labor and Delivery Clinical Trial
Updated: 6/16/2016
Epidural Loading: High Volume, Low Concentration
Status: Enrolling
Updated: 6/16/2016
Click here to add this to my saved trials
Atherosclerotic Cardiovascular Disease Clinical Trial
Updated: 12/31/1969
Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-term
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Atherosclerotic Cardiovascular Disease Clinical Trial
Updated: 12/31/1969
Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-term
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Atherosclerotic Cardiovascular Disease Clinical Trial
Updated: 12/31/1969
Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-term
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Provision of TCRγδ T Cells and Memory T Cells Plus Selected Use of Blinatumomab in Naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies Relapsed or Refractory Despite Prior Transplantation
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology Clinical Trial
Updated: 12/31/1969
The Hemophilia Ultrasound Project
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Ovarian Neoplasms Clinical Trial
Updated: 12/31/1969
Phase Ib Study of Anetumab Ravtansine in Combination With Pegylated Liposomal Doxorubicin in Patients With Recurrent Mesothelin-expressing Platinum-resistant Cancer
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Epilepsy, Unspecified, Refractory (Medically) Clinical Trial
Updated: 12/31/1969
MR-Guided Focused Ultrasound in the Treatment of Subcortical Lesional Epilepsy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Menorrhagia Clinical Trial
Updated: 12/31/1969
Ultrasound Appearance of the Endometrium Post Radio-Frequency Ablation
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Glaucoma Clinical Trial
Updated: 12/31/1969
The AGS Second Aqueous Shunt Implant vs. Transscleral Cyclophotocoagulation Treatment Study (ASSISTS)
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Glaucoma Clinical Trial
Updated: 12/31/1969
The AGS Second Aqueous Shunt Implant vs. Transscleral Cyclophotocoagulation Treatment Study (ASSISTS)
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Glaucoma Clinical Trial
Updated: 12/31/1969
The AGS Second Aqueous Shunt Implant vs. Transscleral Cyclophotocoagulation Treatment Study (ASSISTS)
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 12/31/1969
A Study of ASP2215 (Gilteritinib) by Itself, ASP2215 Combined With Azacitidine or Azacitidine by Itself to Treat Adult Patients Who Have Recently Been Diagnosed With Acute Myeloid Leukemia With a FLT3 Gene Mutation and Who Cannot Receive Standard Chemotherapy
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 12/31/1969
A Study of ASP2215 (Gilteritinib) by Itself, ASP2215 Combined With Azacitidine or Azacitidine by Itself to Treat Adult Patients Who Have Recently Been Diagnosed With Acute Myeloid Leukemia With a FLT3 Gene Mutation and Who Cannot Receive Standard Chemotherapy
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 12/31/1969
A Study of ASP2215 (Gilteritinib) by Itself, ASP2215 Combined With Azacitidine or Azacitidine by Itself to Treat Adult Patients Who Have Recently Been Diagnosed With Acute Myeloid Leukemia With a FLT3 Gene Mutation and Who Cannot Receive Standard Chemotherapy
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 12/31/1969
A Study of ASP2215 (Gilteritinib) by Itself, ASP2215 Combined With Azacitidine or Azacitidine by Itself to Treat Adult Patients Who Have Recently Been Diagnosed With Acute Myeloid Leukemia With a FLT3 Gene Mutation and Who Cannot Receive Standard Chemotherapy
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 12/31/1969
A Study of ASP2215 (Gilteritinib) by Itself, ASP2215 Combined With Azacitidine or Azacitidine by Itself to Treat Adult Patients Who Have Recently Been Diagnosed With Acute Myeloid Leukemia With a FLT3 Gene Mutation and Who Cannot Receive Standard Chemotherapy
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Glaucoma Clinical Trial
Updated: 12/31/1969
Optical Coherence Tomography (OCT) Reference Data Collection Study (S-2015-1)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Updated: 5/8/2017
Expanded Access Program for Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
Status: Enrolling,
Phase
III
Updated: 5/8/2017
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Updated: 5/8/2017
Expanded Access Program for Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
Status: Enrolling,
Phase
III
Updated: 5/8/2017
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Updated: 5/8/2017
Expanded Access Program for Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
Status: Enrolling,
Phase
III
Updated: 5/8/2017
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Updated: 5/8/2017
Expanded Access Program for Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
Status: Enrolling,
Phase
III
Updated: 5/8/2017
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Updated: 5/8/2017
Expanded Access Program for Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
Status: Enrolling,
Phase
III
Updated: 5/8/2017
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Updated: 5/8/2017
Expanded Access Program for Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
Status: Enrolling,
Phase
III
Updated: 5/8/2017
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Updated: 5/8/2017
Expanded Access Program for Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
Status: Enrolling,
Phase
III
Updated: 5/8/2017
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Updated: 5/8/2017
Expanded Access Program for Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
Status: Enrolling,
Phase
III
Updated: 5/8/2017
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Updated: 5/8/2017
Expanded Access Program for Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
Status: Enrolling,
Phase
III
Updated: 5/8/2017
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Updated: 5/8/2017
Expanded Access Program for Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
Status: Enrolling,
Phase
III
Updated: 5/8/2017
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Updated: 5/8/2017
Expanded Access Program for Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
Status: Enrolling,
Phase
III
Updated: 5/8/2017
Click here to add this to my saved trials
Duchenne Muscular Dystrophy (DMD) Clinical Trial
Updated: 4/25/2018
A Phase III Double-blind Study With Idebenone in Patients With Duchenne Muscular Dystrophy (DMD) Taking Glucocorticoid Steroids
Status: Enrolling,
Phase
III
Updated: 4/25/2018
Click here to add this to my saved trials
Fabry Disease Clinical Trial
Updated: 12/31/1969
Study of the Safety and Efficacy of PRX-102 Compared to Agalsidase Beta on Renal Function
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Fabry Disease Clinical Trial
Updated: 12/31/1969
Study of the Safety and Efficacy of PRX-102 Compared to Agalsidase Beta on Renal Function
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Fracture Clinical Trial
Updated: 12/31/1969
Optimal Vitamin D3 Supplementation Strategies for Acute Fracture Healing
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Dravet Syndrome Clinical Trial
Updated: 12/31/1969
An Open-Label Extension Trial to Assess the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride HCl) Oral Solution in Children and Young Adults With Dravet Syndrome
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Dravet Syndrome Clinical Trial
Updated: 12/31/1969
An Open-Label Extension Trial to Assess the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride HCl) Oral Solution in Children and Young Adults With Dravet Syndrome
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Dravet Syndrome Clinical Trial
Updated: 12/31/1969
An Open-Label Extension Trial to Assess the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride HCl) Oral Solution in Children and Young Adults With Dravet Syndrome
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Normal Physiology Clinical Trial
Updated: 12/31/1969
Genomic Responses of Human Immune and Non-Immune Cells to Glucocorticoids
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Leukemia, Myeloid, Acute Clinical Trial
Updated: 12/31/1969
A Trial to Find and Investigate a Safe Dose of BI 836858 in Combination With Decitabine for Patients With Acute Myeloid Leukemia (AML)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology Clinical Trial
Updated: 12/31/1969
A Study of LY2951742 (Galcanezumab) in Participants With Cluster Headache
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology Clinical Trial
Updated: 12/31/1969
A Study of LY2951742 (Galcanezumab) in Participants With Cluster Headache
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology Clinical Trial
Updated: 12/31/1969
A Study of LY2951742 (Galcanezumab) in Participants With Cluster Headache
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology Clinical Trial
Updated: 12/31/1969
A Study of LY2951742 (Galcanezumab) in Participants With Cluster Headache
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrine Diseases Clinical Trial
Updated: 12/31/1969
Evaluation of Adults With Endocrine and Metabolic-Related Conditions
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Early Breast Cancer Clinical Trial
Updated: 12/31/1969
Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Early Breast Cancer Clinical Trial
Updated: 12/31/1969
Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Early Breast Cancer Clinical Trial
Updated: 12/31/1969
Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Early Breast Cancer Clinical Trial
Updated: 12/31/1969
Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Early Breast Cancer Clinical Trial
Updated: 12/31/1969
Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Early Breast Cancer Clinical Trial
Updated: 12/31/1969
Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Early Breast Cancer Clinical Trial
Updated: 12/31/1969
Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Early Breast Cancer Clinical Trial
Updated: 12/31/1969
Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Early Breast Cancer Clinical Trial
Updated: 12/31/1969
Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Early Breast Cancer Clinical Trial
Updated: 12/31/1969
Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Neuroblastoma Clinical Trial
Updated: 7/12/2016
Post-Marketing Assessment of Immunogenicity and Safety of Unituxin™ in High-Risk Neuroblastoma Patients
Status: Enrolling,
Phase
IV
Updated: 7/12/2016
Click here to add this to my saved trials
Neuroblastoma Clinical Trial
Updated: 7/12/2016
Post-Marketing Assessment of Immunogenicity and Safety of Unituxin™ in High-Risk Neuroblastoma Patients
Status: Enrolling,
Phase
IV
Updated: 7/12/2016
Click here to add this to my saved trials
Neuroblastoma Clinical Trial
Updated: 7/12/2016
Post-Marketing Assessment of Immunogenicity and Safety of Unituxin™ in High-Risk Neuroblastoma Patients
Status: Enrolling,
Phase
IV
Updated: 7/12/2016
Click here to add this to my saved trials
Neuroblastoma Clinical Trial
Updated: 7/12/2016
Post-Marketing Assessment of Immunogenicity and Safety of Unituxin™ in High-Risk Neuroblastoma Patients
Status: Enrolling,
Phase
IV
Updated: 7/12/2016
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Updated: 12/31/1969
An Observational Study of Presentation, Treatment Patterns, and Outcomes in Multiple Myeloma Participants
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Updated: 12/31/1969
An Observational Study of Presentation, Treatment Patterns, and Outcomes in Multiple Myeloma Participants
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Updated: 12/31/1969
An Observational Study of Presentation, Treatment Patterns, and Outcomes in Multiple Myeloma Participants
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Updated: 12/31/1969
An Observational Study of Presentation, Treatment Patterns, and Outcomes in Multiple Myeloma Participants
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Psychiatry / Psychology Clinical Trial
Updated: 12/31/1969
Exercise in Adults With Mild Memory Problems
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials